Hostname: page-component-586b7cd67f-t7czq Total loading time: 0 Render date: 2024-11-28T12:58:53.608Z Has data issue: false hasContentIssue false
  • English
  • Français

Illicit drug use and co-morbidities: a gender perspective

Published online by Cambridge University Press:  19 July 2023

M. Torrens
M. Torrens*
Affiliation:
1IMIM-Hospital del Mar Research Institut, Barcelona 2Universitat De Vic-Central Catalunya, Vic 3Universitat Autònma Barcelona, Bellaterra, Spain

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Abstract

At the global level, women are more likely than men to misuse pharmaceutical drugs, particularly pharmaceutical opioids and tranquillizers. By contrast women are three times less likely than men to use cannabis, cocaine or amphetamines and one in five people who inject drugs are women.This mainly reflects differences in opportunities to use drugs owing to the influence of social or cultural environments, rather than intrinsic gender vulnerability. The scientific literature shows that processes of drug use initiation, social factors and characteristics affecting people who use drugs, biological factors and progression to the development of drug use disorders vary considerably between men and women. In this presentation we will present the main characteristics at bio-psycho-social level, including mental (i.e, Depression, Post- Traumatic Stress disorder) and physical comorbidities (i.e. HIV, HCV) of women with illicit drug use disorders. Finally, there will be a reflection on the different difficulties that women who use drugs have in accessing treatment.

Disclosure of Interest

M. Torrens Consultant of: MT has been a consultant/advisor and/or speaker for Gilead Sciences, Camurus, Servier, Adamed, Lundbeck, Otzuka, Angelini, Molteni

Type
Abstract
Information
European Psychiatry , Volume 66 , Special Issue S1: Abstracts of the 31st European Congress of Psychiatry , March 2023 , pp. S34
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright
© The Author(s), 2023. Published by Cambridge University Press on behalf of the European Psychiatric Association
Submit a response

Comments

No Comments have been published for this article.